Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Joint Commission urges caution in imaging

You may also be interested in...



People In Brief

New CEOs at Nephros and Crescent Diagnostics, plus a new name and CEO for transcatheter valve accessory company. More people briefs.

Cyberonics: Aspire Generator Recall Won’t Affect VNS Therapy Sales

Cyberonics aims to submit a repair plan to FDA by April 2012 for its AspireHC vagus nerve stimulation therapy generator for epilepsy treatment following a recall of the device announced Aug. 15.

Panel Supports Sapien But Urges Cautious Rollout

Edwards Lifesciences’ Sapien transcatheter aortic valve met widespread expectations last week by gaining support for FDA approval from an agency advisory panel, but the experts urged FDA and Edwards to proceed cautiously.

Related Content

Topics

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel